DOI: 10.36347/sjams.2018.v06i04.083

Pages: 1778-1781

Abnormal uterine bleeding is defined as a change in frequency of menstruation, duration of flow and amount of blood loss. It is a significant contributor to the deterioration of quality of life in women. Thermal balloon endometrial ablation also known as uterine balloon therapy is a non hysteroscopic ablative device used for endometrial destruction without visual control [1]. This system is introduced by Neuwirth RS et al. It has been considered safe and effective in treating abnormal uterine bleeding when other therapies are contraindicated or difficult to perform [2]. To determine the success rate and predictors of successful outcome of uterine balloon endometrial ablation in treatment of abnormal uterine bleeding in medically morbid women. A prospective study was conducted at department of Obstetrics and Gynecology of a tertiary care hospital during the year of 2011-2012. Twenty eight women with abnormal uterine bleeding and without any detectable pathology treated with uterine balloon therapy were included in study and outcome was assessed at one, three and six months after procedure. After uterine balloon endometrial ablation, 82.1% women had successful outcome at 6 months follow up. Favourable outcome was seen more in patients with endometrial thickness < 8 mm and in patients with uterine cavity length < 10 cm. uterine balloon therapy is an effective, safe, minimally invasive, permanent, non-hormonal procedure for abnormal uterine bleeding in high risk patients. Endometrial thickness and uterine cavity length could be used as predictors of outcome.